跳至主要内容
临床试验/CTRI/2025/12/098994
CTRI/2025/12/098994尚未招募不适用

Effectiveness of supplementing Vitamin C, Vitamin D3 and Zinc among Pulmonary tuberculosis Adult patients at Puducherry - A Randomized Controlled Trial

Dhivya SR2 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2025年12月23日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
200
试验地点
2
主要终点
Cure rate by sputum confirmation

研究概览

简要总结

This study mainly focuses to assess the treatment outcome of Pulmonary Tuberculosis by categorizing the study participants into 2 groups. A total of 200 study participants will be randomized and adults diagnosed with drug sensitive pulmonary Tuberculosis will be randomly assigned to receive to receive either standard ATT ( control group ) or standard ATT plus oral supplements with Vitamin C, D3 and Zinc ( interventional group). Thus this study evaluates the effect of Vitamin C, D3 and Zinc supplementation on treatment outcome among adults with drug sensitive pulmonary Tuberculosis.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Sputum positive adults with drug sensitive tuberculosis above 18 years.

排除标准

  • Pregnancy, lactating mothers and those with known allergies or contraindication to study supplements.

结局指标

主要结局

Cure rate by sputum confirmation

时间窗: After 2 months of treatment

次要结局

  • Reduction in inflammatory markers ( TNF - alpha & IL-6 )(After 2 months of treatment)

研究者

发起方
Dhivya SR
申办方类型
Other [Self funding]
责任方
Principal Investigator
主要研究者

Dr Dhivya SR

Aarupadai Veedu Medical College and Hospital

研究点 (2)

Loading locations...

相似试验